Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04771845
Other study ID # 20-0812
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2008
Est. completion date May 30, 2020

Study information

Verified date February 2021
Source The New York Memory Services
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators reviewed 12 years of clinical use in an outpatient neurology setting of transcranial magnetic stimulation (TMS) in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI) to evaluate safety and efficacy of TMS.


Description:

The investigators compiled demographic, clinical, and neurocognitive data on all patients who had received TMS for any reason in the clinic over a 12-year period. Of 236 patients receiving TMS, 59 patients with AD and 14 with MCI satisfied study criteria and were compared to controls from the National Alzheimer's Coordinating Center (NACC). Neurocognitive outcomes were compared between magnetic resonance imaging (MRI) and electroencephalogram (EEG)-grid guided TMS in patients. Tolerability data was reviewed for all patients.


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date May 30, 2020
Est. primary completion date May 30, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients meeting the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer's Disease and Related Disorders Association (NINCDS- ADRDA) criteria for possible or probable Alzheimer's disease. - Patients meeting the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer's Disease and Related Disorders Association (NINCDS- ADRDA) criteria for mild cognitive impairment. - Patients must have undergone at least two standardized neurocognitive batteries before and after beginning TMS. - Patients must have received greater than or equal to five (5) TMS sessions in less than one year. Exclusion Criteria: • Patients with dementias from other causes, such as Lewy Body disease.

Study Design


Intervention

Device:
Transcranial Magnetic Stimulation
Magnetic stimulation to alter neural activity

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
The New York Memory Services

Outcome

Type Measure Description Time frame Safety issue
Primary Controlled Oral Word Association Test Animal score and percentile 05/01/2008-05/30/2020
Primary Boston 30-item naming test spontaneous correct (without cues) 05/01/2008-05/30/2020
Primary Boston 30-item naming test total correct (with cues) 05/01/2008-05/30/2020
Primary Wechsler Adult Intelligence Scale III Digit span 05/01/2008-05/30/2020
Primary Wechsler Adult Intelligence Scale III verbal quotient score and percentile 05/01/2008-05/30/2020
Primary Wechsler Adult Intelligence Scale III performance quotient score and percentile 05/01/2008-05/30/2020
Primary Wechsler Adult Intelligence Scale III object assembly 05/01/2008-05/30/2020
Primary Wechsler Memory Scale III Immediate memory score and percentile 05/01/2008-05/30/2020
Primary Wechsler Memory Scale III Auditory delayed memory score and percentile 05/01/2008-05/30/2020
Primary Wechsler Memory Scale III Visual delayed memory score and percentile 05/01/2008-05/30/2020
Primary Buschke Selective Reminding Test, 12 item Total recall score 05/01/2008-05/30/2020
Primary Buschke Selective Reminding Test, 12 item, 15 minute Delayed recall score 05/01/2008-05/30/2020
Primary Rosen Drawing Test Total score 05/01/2008-05/30/2020
Primary Processing speed Total score and percentile 05/01/2008-05/30/2020
Primary Mini-mental status examination Total score 05/01/2008-05/30/2020
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A